ENTRY       D04463            Mixture   Drug
NAME        Norgestrel and ethinylestradiol tablets (JP18);
            Low-ogestrel (TN);
            Planovar (TN)
PRODUCT
  GENERIC   CRYSELLE (A-S Medication Solutions)
            CRYSELLE (Preferred Pharmaceuticals)
            CRYSELLE (Proficient Rx LP)
            CRYSELLE (RPK Pharmaceuticals)
            CRYSELLE (Teva Pharmaceuticals USA)
            ELINEST (Northstar Rx LLC)
            LOW-OGESTREL (Mayne Pharma)
            LOW-OGESTREL (RPK Pharmaceuticals)
            TURQOZ (Lupin Pharmaceuticals)
COMPONENT   Norgestrel [DR:D00954], Ethinylestradiol [DR:D00554]
CLASS       Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2482
            ATC code: G03AA06 G03FA10 G03FB01
            Product: D04463<JP/US>
EFFICACY    Contraceptive, Menstruation disorder agent
COMMENT     Combination of estrogen and progestin
            Ethinylestradiol is a substrate for CYP3A4, CYP2C9 and CYP2C19.
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
                G03AA Progestogens and estrogens, fixed combinations
                 G03AA06 Norgestrel and ethinylestradiol
                  D04463  Norgestrel and ethinylestradiol tablets (JP18) &lt;JP/US&gt;
               G03F PROGESTOGENS AND ESTROGENS IN COMBINATION
                G03FA Progestogens and estrogens, fixed combinations
                 G03FA10 Norgestrel and estrogen
                  D04463  Norgestrel and ethinylestradiol tablets (JP18) &lt;JP/US&gt;
                G03FB Progestogens and estrogens, sequential preparations
                 G03FB01 Norgestrel and estrogen
                  D04463  Norgestrel and ethinylestradiol tablets (JP18) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               248  Mixed hormone preparations
                2482  Estrogens and progestins
                 D04463  Norgestrel and ethinylestradiol tablets (JP18)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D04463  Norgestrel and ethinylestradiol tablets
              DG01639  CYP2C19 substrate
               D04463  Norgestrel and ethinylestradiol tablets
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D04463  Norgestrel and ethinylestradiol tablets
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D04463  Norgestrel and ethinylestradiol tablets
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04463
DBLINKS     PubChem: 17398116
///
